TY - CHAP AU - Ferlay, J. AU - Soerjomataram, I. AU - Ervik, M. AU - Dikshit, R. AU - Eser, S. AU - Mathers, C. AU - Rebelo, M. AU - Parkin, D. M. AU - Forman, D. AU - Bray, F. PY - 2013 DA - 2013// BT - Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 PB - International Agency for Research on Cancer CY - Lyon, France ID - Ferlay2013 ER - TY - JOUR AU - Keefe, D. M. AU - Bateman, E. H. PY - 2012 DA - 2012// TI - Tumor control versus adverse events with targeted anticancer therapies JO - Nat Rev Clin Oncol VL - 9 UR - https://doi.org/10.1038/nrclinonc.2011.192 DO - 10.1038/nrclinonc.2011.192 ID - Keefe2012 ER - TY - JOUR AU - Hahn, E. A. AU - Glendenning, G. A. AU - Sorensen, M. V. AU - Hudgens, S. A. AU - Druker, B. J. AU - Guilhot, F. AU - Larson, R. A. AU - O'Brien, S. G. AU - Dobrez, D. G. AU - Hensley, M. L. AU - Cella, D. PY - 2003 DA - 2003// TI - Quality of life in patients with newly diagnosed chronic phase chronic myeloid leukemia on imatinib versus interferon alfa plus low-dose cytarabine: results from the IRIS Study JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.12.154 DO - 10.1200/JCO.2003.12.154 ID - Hahn2003 ER - TY - JOUR AU - Efficace, F. AU - Baccarani, M. AU - Breccia, M. AU - Alimena, G. AU - Rosti, G. AU - Cottone, F. AU - Deliliers, G. L. AU - Barate, C. AU - Rossi, A. R. AU - Fioritoni, G. AU - Luciano, L. AU - Turri, D. AU - Martino, B. AU - Di Raimondo, F. AU - Dabusti, M. AU - Bergamaschi, M. AU - Leoni, P. AU - Simula, M. P. AU - Levato, L. AU - Ulisciani, S. AU - Veneri, D. AU - Sica, S. AU - Rambaldi, A. AU - Vignetti, M. AU - Mandelli, F. PY - 2011 DA - 2011// TI - Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population JO - Blood VL - 118 UR - https://doi.org/10.1182/blood-2011-04-347575 DO - 10.1182/blood-2011-04-347575 ID - Efficace2011 ER - TY - JOUR AU - Basch, E. AU - Abernethy, A. P. AU - Mullins, C. D. AU - Reeve, B. B. AU - Smith, M. L. AU - Coons, S. J. AU - Sloan, J. AU - Wenzel, K. AU - Chauhan, C. AU - Eppard, W. AU - Frank, E. S. AU - Lipscomb, J. AU - Raymond, S. A. AU - Spencer, M. AU - Tunis, S. PY - 2012 DA - 2012// TI - Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2012.42.5967 DO - 10.1200/JCO.2012.42.5967 ID - Basch2012 ER - TY - JOUR AU - Osoba, D. AU - Tannock, I. F. AU - Ernst, D. S. AU - Neville, A. J. PY - 1999 DA - 1999// TI - Health-related quality of life in men with metastatic prostate cancer treated with prednisone alone or mitoxantrone and prednisone JO - J Clin Oncol VL - 17 ID - Osoba1999 ER - TY - JOUR AU - Johnson, J. R. AU - Williams, G. AU - Pazdur, R. PY - 2003 DA - 2003// TI - End points and united states food and drug administration approval of oncology drugs JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.08.072 DO - 10.1200/JCO.2003.08.072 ID - Johnson2003 ER - TY - JOUR AU - Calvert, M. AU - Brundage, M. AU - Jacobsen, P. B. AU - Schunemann, H. J. AU - Efficace, F. PY - 2013 DA - 2013// TI - The CONSORT Patient-Reported Outcome (PRO) extension: implications for clinical trials and practice JO - Health Qual Life Outcomes VL - 11 UR - https://doi.org/10.1186/1477-7525-11-184 DO - 10.1186/1477-7525-11-184 ID - Calvert2013 ER - TY - JOUR AU - Fayers, P. M. AU - Hopwood, P. AU - Harvey, A. AU - Girling, D. J. AU - Machin, D. AU - Stephens, R. PY - 1997 DA - 1997// TI - Quality of life assessment in clinical trials–guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience. MRC Cancer Trials Office JO - Eur J Cancer VL - 33 UR - https://doi.org/10.1016/S0959-8049(96)00412-1 DO - 10.1016/S0959-8049(96)00412-1 ID - Fayers1997 ER - TY - JOUR AU - Chassany, O. AU - Sagnier, P. AU - Marquis, P. AU - Fullerton, S. AU - Aaronson, N. PY - 2002 DA - 2002// TI - Patient-reported outcomes: the example of health-related quality of life – a European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process JO - Drug Inf J VL - 36 UR - https://doi.org/10.1177/009286150203600127 DO - 10.1177/009286150203600127 ID - Chassany2002 ER - TY - JOUR AU - Aaronson, N. K. AU - Ahmedzai, S. AU - Bergman, B. AU - Bullinger, M. AU - Cull, A. AU - Duez, N. J. AU - Filiberti, A. AU - Flechtner, H. AU - Fleishman, S. B. AU - de Haes, J. C. AU - Kaasa, S. AU - Klee, M. AU - Osoba, D. AU - Razavi, D. AU - Rofe, P. AU - Schraub, S. AU - Sneeuw, K. AU - Sullivan, M. AU - Takeda, F. PY - 1993 DA - 1993// TI - The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology JO - J Natl Cancer Inst VL - 85 UR - https://doi.org/10.1093/jnci/85.5.365 DO - 10.1093/jnci/85.5.365 ID - Aaronson1993 ER - TY - JOUR AU - Bottomley, A. AU - Therasse, P. PY - 2002 DA - 2002// TI - Quality of life in patients undergoing systemic therapy for advanced breast cancer JO - Lancet Oncol VL - 3 UR - https://doi.org/10.1016/S1470-2045(02)00876-8 DO - 10.1016/S1470-2045(02)00876-8 ID - Bottomley2002 ER - TY - JOUR AU - Bottomley, A. AU - Efficace, F. AU - Thomas, R. AU - Vanvoorden, V. AU - Ahmedzai, S. H. PY - 2003 DA - 2003// TI - Health-related quality of life in non-small-cell lung cancer: methodologic issues in randomized controlled trials JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.01.203 DO - 10.1200/JCO.2003.01.203 ID - Bottomley2003 ER - TY - JOUR AU - Efficace, F. AU - Bottomley, A. AU - Vanvoorden, V. AU - Blazeby, J. M. PY - 2004 DA - 2004// TI - Methodological issues in assessing health-related quality of life of colorectal cancer patients in randomised controlled trials JO - Eur J Cancer VL - 40 UR - https://doi.org/10.1016/j.ejca.2003.10.012 DO - 10.1016/j.ejca.2003.10.012 ID - Efficace2004 ER - TY - JOUR AU - Efficace, F. AU - Bottomley, A. AU - van Andel, G. PY - 2003 DA - 2003// TI - Health related quality of life in prostate carcinoma patients: a systematic review of randomized controlled trials JO - Cancer VL - 97 UR - https://doi.org/10.1002/cncr.11065 DO - 10.1002/cncr.11065 ID - Efficace2003 ER - TY - JOUR AU - Bottomley, A. AU - Efficace, F. AU - Fayers, P. M. PY - 2002 DA - 2002// TI - Standards are needed for quality of life clinical trials JO - BMJ VL - 324 UR - https://doi.org/10.1136/bmj.324.7346.1156 DO - 10.1136/bmj.324.7346.1156 ID - Bottomley2002 ER - TY - JOUR AU - Efficace, F. AU - Bottomley, A. AU - Osoba, D. AU - Gotay, C. AU - Flechtner, H. AU - D'Haese, S. AU - Zurlo, A. PY - 2003 DA - 2003// TI - Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials–does HRQOL evaluation in prostate cancer research inform clinical decision making? JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.12.121 DO - 10.1200/JCO.2003.12.121 ID - Efficace2003 ER - TY - JOUR AU - Brundage, M. AU - Blazeby, J. AU - Revicki, D. AU - Bass, B. AU - de Vet, H. AU - Duffy, H. AU - Efficace, F. AU - King, M. AU - Lam, C. L. AU - Moher, D. AU - Scott, J. AU - Sloan, J. AU - Snyder, C. AU - Yount, S. AU - Calvert, M. PY - 2013 DA - 2013// TI - Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards JO - Qual Life Res VL - 22 UR - https://doi.org/10.1007/s11136-012-0252-1 DO - 10.1007/s11136-012-0252-1 ID - Brundage2013 ER - TY - JOUR AU - Calvert, M. AU - Blazeby, J. AU - Altman, D. G. AU - Revicki, D. A. AU - Moher, D. AU - Brundage, M. D. PY - 2013 DA - 2013// TI - Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension JO - JAMA VL - 309 UR - https://doi.org/10.1001/jama.2013.879 DO - 10.1001/jama.2013.879 ID - Calvert2013 ER - TY - JOUR AU - Higgins, J. P. AU - Altman, D. G. AU - Gotzsche, P. C. AU - Juni, P. AU - Moher, D. AU - Oxman, A. D. AU - Savovic, J. AU - Schulz, K. F. AU - Weeks, L. AU - Sterne, J. A. PY - 2011 DA - 2011// TI - The Cochrane Collaboration's tool for assessing risk of bias in randomised trials JO - BMJ VL - 343 UR - https://doi.org/10.1136/bmj.d5928 DO - 10.1136/bmj.d5928 ID - Higgins2011 ER - TY - CHAP AU - Efficace, F. AU - Feuerstein, M. AU - Fayers, P. AU - Cafaro, V. AU - Eastham, J. AU - Pusic, A. AU - Blazeby, J. PY - 2013 DA - 2013// TI - Patient-reported outcomes in randomised controlled trials of prostate cancer: methodological quality and impact on clinical decision making BT - Eur Urol ID - Efficace2013 ER -